
Ocubil160 mg
Square Pharmaceuticals PLC.
Bilberry fruit [Vaccinium myrtillus L] is a herbal (dietary supplement) product, not an FDA-approved conventional drug.
Bilberry fruit [Vaccinium myrtillus L] is a herbal (dietary supplement) product, not an FDA-approved conventional drug. Its traditional and commonly marketed uses, graded by strength of evidence, are as follows:
Overall clinical trial evidence for most of these claims is limited, of variable quality, and not sufficient to establish Bilberry fruit [Vaccinium myrtillus L] as a proven treatment for any diagnosed eye disease (e.g., cataract, macular degeneration, diabetic retinopathy, glaucoma) or vascular disorder. It should not be used as a substitute for conventional medical evaluation or treatment of such conditions.
There is no single internationally standardized dose for Bilberry fruit [Vaccinium myrtillus L]; dosing varies by product strength and standardization. The following reflects commonly used ranges for standardized extract (approximately 25% anthocyanosides), for general reference only:
| Use | Typical Adult Dose | Notes |
|---|---|---|
| General eye/antioxidant support | 80-120 mg of standardized extract, 1-3 times daily | With food, per product labeling |
| Vascular/circulatory support | Up to 240-480 mg standardized extract per day, in divided doses | Per product labeling; not a substitute for prescribed treatment of venous disease |
| Pediatric use | Not established | See Use in Special Populations |
Always follow the specific product label or a physician's/qualified healthcare provider's advice, as concentration and standardization differ between brands.
Bilberry fruit [Vaccinium myrtillus L] is generally well tolerated when used as directed. Reported side effects are usually mild and may include:
Allergic reactions are uncommon but possible (see Contraindications). Patients on anticoagulant/antiplatelet therapy or with diabetes should be alert to increased bleeding tendency or low blood sugar, respectively (see Interactions and Precautions).
Bilberry fruit [Vaccinium myrtillus L] is contraindicated in patients with known hypersensitivity to bilberry, other Vaccinium species, or any component of the formulation.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.